Blood-based biomarkers identified for early inflammatory breast cancer diagnosis

[News]

Researchers at The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have identified specific blood-based genomic biomarkers that distinguish inflammatory breast cancer from other subtypes, providing a new and less invasive method for early diagnosis, disease progression monitoring and treatment development for patients with this aggressive disease.

More... (https://www.news-medical.net/news/20260506/Blood-based-biomarkers-identified-for-early-inflammatory-breast-cancer-diagnosis.aspx)